1 Department of Otolaryngology-Head and Neck Surgery, Stanford University School of Medicine, Stanford, California, USA.
2 Department of Otolaryngology, Oregon Health and Science University, Portland, Oregon, USA.
Otolaryngol Head Neck Surg. 2018 Apr;158(4):767-773. doi: 10.1177/0194599818755340. Epub 2018 Feb 20.
Objectives Venous thromboembolism (VTE) contributes to significant patient morbidity, yet the incidence of VTE following endoscopic sinus surgery (ESS) is unknown. Quality improvement criteria are prompting increased standardization of perioperative VTE prophylaxis. Risk stratification for VTE may better define best practice measures to balance limiting VTE development with avoiding unnecessary chemoprophylaxis. Study Design Retrospective cohort study. Setting Tertiary institution. Subjects and Methods Adult patients who underwent ESS without perioperative chemoprophylaxis from 2008 to 2016 were evaluated. Identification of VTE was performed via screening diagnosis and procedure codes and clinical records, with subsequent confirmation of true-positive VTE. Data for individual Caprini scores were abstracted from electronic medical records. The primary outcome was development of VTE within 30 days following ESS relative to the Caprini score. Results A total of 2369 ESS cases were evaluated. While initial screening identified multiple potential VTE events, in-depth medical record review confirmed only 4 true VTE (0.17%). The VTE rate among cases with a Caprini score of <8 (0.09%, 2/2278) was significantly less ( P = .008) than the rate with a score of ≥8 (2.2%, 2/91). Beyond overall score, specific risk factors associated with development of postoperative VTE included stroke, central venous access, sepsis, and inpatient status (all P < .025), while prior VTE and hypercoagulability were not associated with postoperative VTE (all P > .5). Conclusions In the absence of perioperative chemoprophylaxis, postoperative VTE following ESS is extremely rare, particularly for patients carrying low-to-moderate Caprini scores. Risk stratification based on these data can assist in the design of VTE prophylaxis guidelines for ESS patients.
静脉血栓栓塞症(VTE)会导致患者出现严重的疾病,但目前尚不清楚内镜鼻窦手术(ESS)后 VTE 的发生率。质量改进标准促使围手术期 VTE 预防措施更加标准化。VTE 的风险分层可以更好地定义最佳实践措施,在限制 VTE 发展的同时避免不必要的化学预防。
回顾性队列研究。
三级机构。
评估了 2008 年至 2016 年间接受 ESS 且无围手术期化学预防的成年患者。通过筛选诊断和程序代码以及临床记录来确定 VTE 的发生,并随后对真正的 VTE 进行确认。从电子病历中提取每个 Caprini 评分的个体数据。主要结果是 ESS 后 30 天内 VTE 的发生情况与 Caprini 评分相关。
共评估了 2369 例 ESS 病例。虽然初始筛选确定了多个潜在的 VTE 事件,但深入的病历审查仅确认了 4 例真正的 VTE(0.17%)。Caprini 评分<8(0.09%,2/2278)的病例 VTE 发生率明显较低(P=0.008),而评分≥8(2.2%,2/91)的病例 VTE 发生率较高。除了总评分外,与术后 VTE 发生相关的特定危险因素包括中风、中心静脉通路、败血症和住院状态(均 P<0.025),而既往 VTE 和高凝状态与术后 VTE 无关(均 P>0.5)。
在没有围手术期化学预防的情况下,ESS 后发生术后 VTE 的情况极为罕见,尤其是 Caprini 评分较低至中等的患者。基于这些数据的风险分层有助于为 ESS 患者制定 VTE 预防指南。